- KYMR +1.21%
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Yahoo Finance · 1 week ago
Open | 37.91 |
High | 39.02 |
Low | 37.91 |
Mkt Cap | 2.35B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 37.90 |
52 Wk. Low | 9.60 |
52 Wk. High | 45.31 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 10.29M | 8.70% ▲ |
Net Income | -48.56M | - |
Diluted EPS | -0.69 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.68 | - |
Q1 2024 | -$0.73 | -$0.69 |
Q4 2023 | -$0.40 | -$0.25 |
S&P FuturesES=F | 5,244.50-1.00 (-0.02%) |
Dow FuturesYM=F | 39,566.00+7.00 (+0.02%) |
Nasdaq FuturesNQ=F | 18,278.00-17.50 (-0.10%) |
30.45+74.40% | |
5.19+78.35% | |
3.1000+6.90% |